Cutter & CO Brokerage Inc. Acquires 134 Shares of Cardinal Health, Inc. (NYSE:CAH)

Cutter & CO Brokerage Inc. lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 2.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,644 shares of the company’s stock after acquiring an additional 134 shares during the quarter. Cutter & CO Brokerage Inc.’s holdings in Cardinal Health were worth $668,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Assenagon Asset Management S.A. grew its stake in Cardinal Health by 5.2% in the third quarter. Assenagon Asset Management S.A. now owns 10,930 shares of the company’s stock worth $1,208,000 after purchasing an additional 545 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its stake in Cardinal Health by 21.5% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,049 shares of the company’s stock worth $2,640,000 after purchasing an additional 4,253 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in Cardinal Health by 93.6% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 46,065 shares of the company’s stock worth $5,091,000 after purchasing an additional 22,267 shares during the period. State of Alaska Department of Revenue grew its stake in Cardinal Health by 3.5% in the third quarter. State of Alaska Department of Revenue now owns 57,506 shares of the company’s stock worth $6,354,000 after purchasing an additional 1,920 shares during the period. Finally, Nisa Investment Advisors LLC grew its stake in Cardinal Health by 20.6% in the third quarter. Nisa Investment Advisors LLC now owns 98,389 shares of the company’s stock worth $10,874,000 after purchasing an additional 16,820 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Cardinal Health stock opened at $127.90 on Wednesday. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $132.84. The stock has a market capitalization of $30.90 billion, a PE ratio of 23.86, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. The business’s fifty day moving average is $124.08 and its 200 day moving average is $117.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is 37.69%.

Analyst Upgrades and Downgrades

CAH has been the topic of several recent research reports. Barclays upped their price target on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and upped their price target for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Morgan Stanley increased their target price on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research note on Friday, January 31st. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research note on Tuesday, January 7th. Finally, Citigroup increased their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average price target of $138.40.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.